Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Neurology
|
September 1, 1993
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease
M Vidailhet, F Stocchi, J C Rothwell, et al.
Functional Neurology
|
September 29, 2016
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score
M Galli, V Cimolin, M F De Pandis, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 28, 2003
Modification of respiratory function parameters in patients with severe Parkinson's disease
M F De Pandis, A Starace, F Stefanelli, et al.
Functional Neurology
|
April 6, 2017
The coefficient of friction in Parkinson's disease gait
Ana Kleiner, M Galli, M Franceschini, et al.
Glia
|
January 22, 2010
mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ-derived neural stem cells towards the astrocytic lineage
C Ciceroni, P Mosillo, E Mastrantoni, et al.
European Journal of Neurology
|
September 13, 2012
Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
A H V Schapira, F Stocchi, R Borgohain, et al.
Advances in Neurology
|
January 1, 1984
An appraisal of the problem of dementia in Parkinson's disease
A Agnoli, S Ruggieri, G Meco, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
April 1, 1996
QT interval and QT dispersion in multiple system atrophy (Shy-Drager syndrome)
D Frongillo, F Stocchi, F A Delfino, et al.
Cell Death and Differentiation
|
January 5, 2008
Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons
I Sarichelou, I Cappuccio, F Ferranti, et al.
Clinical Neuropharmacology
|
June 9, 1998
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease
A E Schrag, D J Brooks, E Brunt, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Neurology
|
September 1, 1993
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease
M Vidailhet, F Stocchi, J C Rothwell, et al.
Functional Neurology
|
September 29, 2016
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score
M Galli, V Cimolin, M F De Pandis, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
January 28, 2003
Modification of respiratory function parameters in patients with severe Parkinson's disease
M F De Pandis, A Starace, F Stefanelli, et al.
Functional Neurology
|
April 6, 2017
The coefficient of friction in Parkinson's disease gait
Ana Kleiner, M Galli, M Franceschini, et al.
Glia
|
January 22, 2010
mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ-derived neural stem cells towards the astrocytic lineage
C Ciceroni, P Mosillo, E Mastrantoni, et al.
European Journal of Neurology
|
September 13, 2012
Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
A H V Schapira, F Stocchi, R Borgohain, et al.
Advances in Neurology
|
January 1, 1984
An appraisal of the problem of dementia in Parkinson's disease
A Agnoli, S Ruggieri, G Meco, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
April 1, 1996
QT interval and QT dispersion in multiple system atrophy (Shy-Drager syndrome)
D Frongillo, F Stocchi, F A Delfino, et al.
Cell Death and Differentiation
|
January 5, 2008
Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons
I Sarichelou, I Cappuccio, F Ferranti, et al.
Clinical Neuropharmacology
|
June 9, 1998
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease
A E Schrag, D J Brooks, E Brunt, et al.
Page
of 14